Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/32/43/8d/32438d12-f214-2b84-a090-4cb5c1fd55ff/mza_1588204697638323759.jpg/600x600bb.jpg

Project Oncology®

ReachMD

180 episodes

4 days ago

Showcasing major breakthroughs in cancer care from worldwide clinical trials, Project Oncology® educates and assists the healthcare professionals who dedicate their lives to helping patients fight cancer. Here you’ll find leading oncologists discuss and share essential cancer care strategies for all different types of cancer. And as worldwide clinical trials continue to explore new screening tests and discover novel treatment options, you can rest assured that you’ll always catch the latest in cancer research with Project Oncology®.

Science

Medicine

RSS

All content for Project Oncology® is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing

Project Oncology®

2 months ago

Refining Multimodal Therapy for Mesothelioma: Clinical Impact of SMART Sequencing

Guest: John Cho, MD, PhD, FRCPC

Surgery for mesothelioma after radiation therapy (SMART) offers new hope for patients with resectable epithelioid mesothelioma by reversing the traditional treatment sequence. Hear from Dr. John Cho as he discusses the rationale behind this decade-long clinical advancement, which he spoke about at the 2025 World Conference on Lung Cancer. Dr. Cho is a radiation oncologist at Princess Margaret Cancer Centre and an Associate Professor in the Department of Radiation Oncology at the University of Toronto.